KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Prepaid Assets: 2018-2024

Historic Prepaid Assets for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $7.7 million.

  • Castle Biosciences' Prepaid Assets rose 45.88% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 45.88%. This contributed to the annual value of $7.7 million for FY2024, which is 21.92% up from last year.
  • Castle Biosciences' Prepaid Assets amounted to $7.7 million in FY2024, which was up 21.92% from $6.3 million recorded in FY2023.
  • Castle Biosciences' Prepaid Assets' 5-year high stood at $7.7 million during FY2024, with a 5-year trough of $4.8 million in FY2020.
  • Over the past 3 years, Castle Biosciences' median Prepaid Assets value was $6.3 million (recorded in 2023), while the average stood at $6.7 million.
  • Data for Castle Biosciences' Prepaid Assets shows a peak YoY spiked of 144.28% (in 2020) over the last 5 years.
  • Over the past 5 years, Castle Biosciences' Prepaid Assets (Yearly) stood at $4.8 million in 2020, then climbed by 0.86% to $4.8 million in 2021, then grew by 29.12% to $6.2 million in 2022, then increased by 1.37% to $6.3 million in 2023, then grew by 21.92% to $7.7 million in 2024.